LYMPHANGIOMA

Clinical trials for LYMPHANGIOMA explained in plain language.

Never miss a new study

Get alerted when new LYMPHANGIOMA trials appear

Sign up with your email to follow new studies for LYMPHANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare vascular malformations: targeted drugs enter trial

Disease control Recruiting now

This phase 2 trial is testing two targeted drugs—alpelisib and mirdametinib—in 50 people with slow-flow or fast-flow vascular malformations that haven't responded to standard treatments. The goal is to see if these drugs can improve each person's most bothersome symptom over 48 w…

Matched conditions: LYMPHANGIOMA

Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC

LYMPHANGIOMA

Get alerted when new LYMPHANGIOMA trials appear

New hope for rare vascular malformations: targeted drugs enter trial